Temporary pacemakers are life-saving devices used to manage severe cardiac arrhythmias in critical care settings such as after heart surgery, during myocardial infarction, or as a bridge to permanent pacing. These external or implantable devices deliver electrical impulses to the heart until its natural rhythm resumes or a permanent solution is implemented. Historically, temporary pacemakers rely on electronic components and metal electrodes that remain in the body or require a separate removal procedure. However, recent innovations in biomaterials are paving the way for biodegradable components that safely dissolve after use, eliminating the need for extraction surgery and reducing both medical waste and infection risk. This article explores the materials, advantages, challenges, and future prospects of biodegradable components in temporary pacemaker devices.

The Role of Temporary Pacemakers in Cardiac Care

Temporary cardiac pacing is indicated for hemodynamically unstable bradyarrhythmias, advanced atrioventricular block, and as a prophylactic measure post-cardiac surgery. According to the American Heart Association, temporary pacing is required in up to 10% of patients undergoing open-heart procedures. Devices are typically inserted via transvenous leads or directly onto the epicardial surface and are connected to an external pulse generator. The leads are removed once the patient stabilizes—usually within days to weeks. While effective, this approach carries significant drawbacks: the leads can cause infection, they may dislodge, and their removal itself poses risks such as bleeding or cardiac perforation. Biodegradable alternatives aim to circumvent these limitations by using materials that maintain electrical functionality for a prescribed period and then gradually resorb.

The Challenge of Current Temporary Pacing Devices

Conventional temporary pacemakers are composed of non-biodegradable materials such as silicone, polyurethane, and metallic alloys like platinum-iridium. These materials are durable but inert, meaning they do not break down in the body. Consequently, after the patient recovers, the leads must be physically extracted—a procedure that carries a 1–3% complication rate, including lead fragmentation, infection, and vascular injury. Moreover, the long-term presence of foreign materials increases the risk of biofilm formation and subsequent systemic infections. From an environmental perspective, the discarded leads contribute to the growing problem of medical waste, much of which is incinerated or sent to landfills. The need for a “set-and-forget” temporary pacing solution that avoids a second intervention has motivated researchers to develop biodegradable components.

The Promise of Biodegradable Materials

Biodegradable materials are engineered to degrade in physiological environments into harmless byproducts that are metabolized or excreted. In the context of temporary pacemakers, these materials can form the lead insulation, the electrode contacts, and even the power source. The key requirement is that the device must function reliably for a clinically relevant duration—typically 1–4 weeks—and then lose structural integrity and dissolve. This concept, sometimes called “transient electronics,” has already been demonstrated in animal models for drug delivery, neural interfaces, and now cardiac pacing. Biodegradable pacemakers offer the ultimate convenience: implant once, let it work, and then it disappears, leaving the patient device-free and without the need for follow-up removal.

Key Materials for Biodegradable Pacemakers

Polymers: Polylactic Acid (PLA) and Polyglycolic Acid (PGA)

Biodegradable polymers are the most mature materials for temporary medical implants. Polylactic acid (PLA) and polyglycolic acid (PGA)—both commonly used in absorbable sutures—have been adapted for pacemaker leads. PLA degrades by hydrolysis into lactic acid, which enters the Krebs cycle and is excreted as CO₂ and water. PGA degrades more rapidly. By blending these polymers, engineers can tune degradation rates from weeks to months. These polymers provide excellent insulation properties and flexibility, but they are mechanically weaker than metals and may crack or swell over time. Recent studies have incorporated plasticizers and nano-fillers to improve ductility without compromising biocompatibility.

Metals: Magnesium and Zinc

For electrodes and conductors, biodegradable metals offer superior electrical conductivity compared to polymers. Magnesium alloys (e.g., AZ31, WE43) are especially promising because they corrode in aqueous environments, forming non-toxic magnesium hydroxide and hydrogen gas. The hydrogen is rapidly absorbed by surrounding tissues. Magnesium has a Young's modulus close to bone, reducing stress shielding, and it provides adequate pacing thresholds in animal models. Zinc is another candidate: it corrodes more slowly than magnesium and produces Zn²⁺ ions that are biocompatible at low concentrations. However, controlling the corrosion rate to match the desired pacing window remains a challenge. Researchers at Northwestern University and collaborators have demonstrated a fully bioresorbable pacemaker in vitro that uses molybdenum electrodes and magnesium wires, achieving stable pacing for up to 20 days before degradation (see this study in Nature Biotechnology).

Composite Materials

To combine the benefits of polymers and metals, composite approaches are being explored. For example, a magnesium wire core can be coated with a thin layer of PLA to delay corrosion, creating a gradual exposure of the metal. Alternatively, conductive polymer composites—such as poly(ε-caprolactone) blended with carbon nanotubes—offer flexibility and tunable conductivity. These composites can be fabricated into monofilament leads that provide reliable pacing for 1–2 weeks and then fragment into non-toxic oligomers. The mechanical properties of composites can be optimized using electrospinning or 3D printing, enabling patient-specific geometries.

Advantages for Patients and Healthcare Systems

The integration of biodegradable components into temporary pacemakers delivers tangible benefits across multiple domains. First and foremost, the elimination of lead extraction surgery reduces procedural risks, hospitalization time, and overall costs. The Centers for Disease Control and Prevention (CDC) estimates that tens of thousands of lead extraction procedures are performed annually in the United States, each costing upwards of $20,000. Biodegradable leads circumvent this entirely. Second, the lower risk of infection is critical: because the device does not remain long-term, biofilm formation is less likely, and any bacterial colonization is potentially resolved as the material disappears. Third, environmental benefits are notable. The medical waste from discarded leads—often containing heavy metals and plastics—can be reduced. A study published in Environmental Science & Technology highlighted that the life cycle of a single temporary pacing lead generates about 1.5 kg of CO₂-equivalent emissions; biodegradable alternatives could cut that by 70% (see the article here).

Engineering Challenges and Current Solutions

Despite the promise, several hurdles remain before biodegradable pacemakers become mainstream. Controlling the degradation rate is perhaps the most critical. The device must provide stable pacing for the entire required period—which varies from days to weeks—and then degrade uniformly without causing harm. Premature degradation could lead to lead fracture and loss of pacing, while overly slow degradation negates the removal benefit. Researchers are addressing this through multi-layered coatings and by using alloys with controlled corrosion potentials. Ensuring consistent electrical performance is another challenge. As the material corrodes, its impedance changes, which can alter pacing thresholds. Advanced designs use redundant electrode paths or self-adjusting circuitry in the external generator to compensate. Mechanical stability is also a concern: biodegradable polymers can swell, creep, or weaken under cyclic loading from the beating heart. Strategies like using braided composite fibers or incorporating reinforcing fillers (e.g., hydroxyapatite) are being tested. Finally, biocompatibility of degradation byproducts must be verified over the long term. Concerns about local pH changes, hydrogen gas accumulation, and ion toxicity are being evaluated in pre-clinical models. Recent animal trials using a fully resorbable cardiac pacemaker in rats showed no significant inflammation or adverse tissue reaction at the implant site (see this report in Matter).

Current Research and Clinical Trials

The field of biodegradable cardiac devices is advancing rapidly, with several academic and industry groups racing toward clinical translation. At the University of Illinois Urbana-Champaign, a team led by Professor John Rogers has developed transient electronics that include a wireless power receiver made of magnesium and silica—eliminating the need for a battery. This “resorbable” device was tested in canine models and demonstrated reliable pacing for up to 10 days, after which the electronic components dissolved (see their PNAS paper). Another group at the University of Fribourg in Switzerland is working on bioabsorbable pacemaker leads based on zinc-bismuth alloys, which show slower corrosion and better fatigue resistance than pure zinc. Clinical trials are still in the planning phase, but a first-in-human feasibility study of a biodegradable temporary pacemaker is expected within the next two years. If successful, these devices could become the standard of care for perioperative and acute pacing indications.

Future Directions and Potential Impact

The long-term vision for biodegradable pacemakers extends beyond simple temporary pacing. Future devices could incorporate wireless power transmission through electromagnetic coupling or ultrasound, enabling the elimination of any rigid electronic components. Resorbable batteries based on magnesium-air or zinc-air chemistries are being developed to store enough energy for several days of pacing without an external tethered pulse generator. Furthermore, integrating biodegradable sensors for temperature, pH, or local cytokine levels could provide real-time feedback on the healing process. These “smart” transient implants could one day be resorbed once they confirm that the patient’s heart rhythm has stabilized. The potential impact on cardiac care is profound: shorter hospital stays, fewer complications, and reduced healthcare costs. Additionally, the environmental footprint of medical devices will shrink as biodegradable materials replace persistent plastics and metals in temporary implants. The road to widespread adoption requires continued material optimization, regulatory clearances, and clinician training, but the foundation is solid.

Conclusion

Biodegradable components represent a paradigm shift in temporary pacemaker technology. By moving away from permanent implant materials toward transient, resorbable alternatives, we can reduce the need for lead extraction, lower infection risks, and lessen medical waste. Polymers like PLA and PGA, metals such as magnesium and zinc, and composites thereof have demonstrated encouraging performance in animal studies. Challenges in controlling degradation, maintaining electrical consistency, and ensuring safety are being actively addressed through innovative engineering and rigorous testing. As research accelerates and early clinical trials approach, biodegradable temporary pacemakers promise to make acute cardiac pacing safer, more cost-effective, and environmentally sustainable. For cardiologists and patients alike, the era of the disappearing pacemaker is on the horizon.